Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

ClinicalTrials.gov ID: NCT05142774

Public ClinicalTrials.gov record NCT05142774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% in Subjects With Atopic Dermatitis

Study identification

NCT ID
NCT05142774
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
728 participants

Conditions and interventions

Interventions

  • Tapinarof cream, 1% Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2021
Primary completion
Feb 28, 2024
Completion
Mar 6, 2024
Last update posted
Aug 12, 2025

2021 – 2024

United States locations

U.S. sites
102
U.S. states
29
U.S. cities
91
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35244
Dermavant Investigative Site Phoenix Arizona 85032
Dermavant Investigative Site Scottsdale Arizona 85255
Dermavant Investigative Site Scottsdale Arizona 85260
Dermavant Investigative Site Bryant Arkansas 72022
Dermavant Investigative Site Fort Smith Arkansas 72916
Dermavant Investigative Site Cerritos California 90702
Dermavant Investigative Site Fountain Valley California 92708
Dermavant Investigative Site Fremont California 94538
Dermavant Investigative Site Huntington Beach California 92647
Dermavant Investigative Site Inglewood California 90301
Dermavant Investigative Site Lancaster California 93534
Dermavant Investigative Site Long Beach California 90806
Dermavant Investigative Site Los Angeles California 90017
Dermavant Investigative Site Los Angeles California 90033
Dermavant Investigative Site Los Angeles California 90045
Dermavant Investigative Site Mission Viejo California 92691
Dermavant Investigative Site Sacramento California 95815
Dermavant Investigative Site San Diego California 92123
Dermavant Investigative Site San Francisco California 94115
Dermavant Investigative Site Santa Ana California 92701
Dermavant Investigative Site Santa Monica California 90404
Dermavant Investigative Site Thousand Oaks California 91320
Dermavant Investigative Site Thornton Colorado 80112
Dermavant Investigative Site Washington D.C. District of Columbia 20037
Dermavant Investigative Site Boca Raton Florida 33428
Dermavant Investigative Site Boca Raton Florida 33486
Dermavant Investigative Site Brandon Florida 33511
Dermavant Investigative Site Coral Gables Florida 33146
Dermavant Investigative Site Delray Beach Florida 33484
Dermavant Investigative Site Hialeah Florida 33016
Dermavant Investigative Site Jacksonville Florida 32256
Dermavant Investigative Site Margate Florida 33063
Dermavant Investigative Site Miami Florida 33165
Dermavant Investigative Site Miami Florida 33173
Dermavant Investigative Site Miami Lakes Florida 33014
Dermavant Investigative Site Orlando Florida 32801
Dermavant Investigative Site Pinellas Park Florida 33781
Dermavant Investigative Site Sweetwater Florida 33172
Dermavant Investigative Site Tampa Florida 33607
Dermavant Investigative Site Marietta Georgia 30060
Dermavant Investigative Site Sandy Springs Georgia 30328
Dermavant Investigative Site Savannah Georgia 31406
Dermavant Investigative Site Snellville Georgia 30078
Dermavant Investigative Site Chicago Illinois 60611
Dermavant Investigative Site Evansville Indiana 47715
Dermavant Investigative Site Plainfield Indiana 46168
Dermavant Investigative Site Overland Park Kansas 66210
Dermavant Investigative Site Lexington Kentucky 40517
Dermavant Investigative Site Louisville Kentucky 40217
Dermavant Investigative Site Louisville Kentucky 40241
Dermavant Investigative Site Owensboro Kentucky 42301
Dermavant Investigative Site Baton Rouge Louisiana 70808
Dermavant Investigative Site Baton Rouge Louisiana 70809
Dermavant Investigative Site Covington Louisiana 70433
Dermavant Investigative Site Monroe Louisiana 71201
Dermavant Investigative Site New Orleans Louisiana 70115
Dermavant Investigative Site Largo Maryland 20774
Dermavant Investigative Site Rockville Maryland 20850
Dermavant Investigative Site Bay City Michigan 48706
Dermavant Investigative Site Clarkston Michigan 48346
Dermavant Investigative Site Warren Michigan 48088
Dermavant Investigative Site Ypsilanti Michigan 48197
Dermavant Investigative Site New Brighton Minnesota 55112
Dermavant Investigative Site Missoula Montana 59808
Dermavant Investigative Site Omaha Nebraska 68144
Dermavant Investigative Site East Windsor New Jersey 08520
Dermavant Investigative Site Garden City New York 11530
Dermavant Investigative Site New York New York 10075
Dermavant Investigative Site Charlotte North Carolina 28277
Dermavant Investigative Site Bexley Ohio 43209
Dermavant Investigative Site Cleveland Ohio 44106
Dermavant Investigative Site Dayton Ohio 45414
Dermavant Investigative Site Mason Ohio 45040
Dermavant Investigative Site Mayfield Heights Ohio 44124
Dermavant Investigative Site Norman Oklahoma 73071
Dermavant Investigative Site Oklahoma City Oklahoma 73120
Dermavant Investigative Site Tulsa Oklahoma 74114
Dermavant Investigative Site Medford Oregon 97504
Dermavant Investigative Site Portland Oregon 97210
Dermavant Investigative Site Portland Oregon 97223
Dermavant Investigative Site Portland Oregon 97239
Dermavant Investigative Site Anderson South Carolina 29621
Dermavant lnvestigative Site Greenville South Carolina 29615
Dermavant Investigative Site Mt. Pleasant South Carolina 29445
Dermavant Investigative Site North Charleston South Carolina 29420
Dermavant Investigative Site Spartanburg South Carolina 29303
Dermavant Investigative Site Knoxville Tennessee 37909
Dermavant Investigative Site Memphis Tennessee 38119
Dermavant Investigative Site Bellaire Texas 77401
Dermavant Investigative Site Cypress Texas 77433
Dermavant Investigative Site Dallas Texas 75230
Dermavant Investigative Site Dripping Springs Texas 78620
Dermavant Investigative Site Grapevine Texas 76051
Dermavant Investigative Site Houston Texas 77004
Dermavant Investigative Site San Antonio Texas 78213
Dermavant Investigative Site San Antonio Texas 78218
Dermavant Investigative Site San Antonio Texas 78229
Dermavant Investigative Site Sugar Land Texas 77479
Dermavant Investigative Site Webster Texas 77598
Dermavant Investigative Site Richmond Virginia 23226
Dermavant Investigative Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05142774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05142774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →